Another two biopharma companies priced IPOs on Nasdaq to raise a combined $350 million, becoming the fourth and fifth firms to debut on U.S. markets in 2026.

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in lipid nanoparticles.

Apple is reportedly preparing to bring a major update to its CarPlay vehicle interface which will enable the drivers to ...

A preview of Manifest 2026, the premier global supply chain and logistics tech event, to be held February 9-11, 2026 at the ...

Prosus has signed a three-year Global Partnership Agreement with Amazon Web Services to accelerate AI adoption across its portfolio companies in Latin America, Europe, and India, enabling businesses ...

Umbraco Compose. Umbraco says the platform will ease the management of data flows in complex enterprise projects. The solution is expected to save enterprises hundreds of development hours and ...

No-code app builders let businesses create powerful apps without developers, cutting costs and build time using visual tools, ...

(Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today released its annual In-Demand Skills report, finding that as demand for top AI-enabled skills more than doubled year-over-year, ...

Research from web.dev.co reveals performance debt, CMS sprawl, and architectural shortcuts are quietly constraining growthSeattle, Washington, ...

Compare composable commerce companies for 2026: delivery models, platform posture, and best-fit use cases across B2B, retail, ...

Enjoy top notch visuals and audio brilliance with these best rated TCL QLED And LED TVs with 4K display. From 75 inch to 32 ...

To be a great creative services manager, you need a solid mix of technical skills and the ability to manage projects and ...